Protagenic Therapeutics’ Innovative Peptide PT00114 to be Highlighted at Boston Summit

Chief Operating Officer to Present Key Advances at Peptide Therapeutics Summit NEW YORK, NY / ACCESSWIRE / April 17, 2024 / Protagenic Therapeutics, Inc. (NASDAQ:PTIX), a pioneer in biopharmaceutical research, announced today that Dr. Andrew Slee, …
Jetzt den vollständigen Artikel lesen